---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-011217"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2021-08-11T23:59:59+00:00"
generated_at: "2026-06-29T15:11:41.684957+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Reneo Pharmaceuticals posts updated corporate slide deck for investor meetings

## Summary
- Presentation available on company website and filed as Exhibit 99.1 to Form 8-K.
- Deck highlights focus on rare genetic mitochondrial diseases.
- No specific financial or clinical data disclosed in the filing itself.

## SEC filing metadata
- accession: 0001558370-21-011217
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2021-08-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000155837021011217/0001558370-21-011217-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000155837021011217/rphm-20210811x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-011217
- JSON: https://secwatch.observer/filing/0001558370-21-011217.json
- Plain text: https://secwatch.observer/filing/0001558370-21-011217.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.